RiskReversal Pod cover image

RiskReversal Mailbag: Your Most Prescient Questions Answered!

RiskReversal Pod

00:00

Health care, pharma re-rating and M&A expectations

Hosts discuss Eli Lilly's uniqueness, potential pharma M&A, GLP‑1 dynamics and names to watch into 2026.

Play episode from 21:52
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app